Proximagen
-
2003
Company Description
Proximagen is a neuroscience research company developing drugs for neurodegenerative disorders, including Parkinson’s and Alzheimers.
Proximagen is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.
-
Manufacturer:
Science and Engineering -
Formed:
2003 -
Company Website:
-
Company E-mail:
-
Company Address:
Hodgkin Building, Guy's CampusUnited KingdomLondon -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits